Macquarie Group LTD Astrazeneca PLC Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

A detailed history of Macquarie Group LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Macquarie Group LTD holds 615,079 shares of AZN stock, worth $43.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

615,079

Previous 417,511 47.32%

Holding current value

$43.5 Million

Previous $32.6 Million 47.19%

% of portfolio

0.05%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $15.1 Million - $17.3 Million	197,568 Added 47.32%	615,079 $47.9 Million
Q2 2024 Aug 09, 2024	SELL	$66.81 - $80.83 $4.98 Million - $6.02 Million	-74,479 Reduced 15.14%	417,511 $32.6 Million
Q1 2024 May 14, 2024	SELL	$61.03 - $69.57 $729,857 - $831,987	-11,959 Reduced 2.37%	491,990 $33.3 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $7,674 - $8,590	124 Added 0.02%	503,949 $33.9 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $759,912 - $840,180	11,718 Added 2.38%	503,825 $34.1 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $1.28 Million - $1.39 Million	-18,316 Reduced 3.59%	492,107 $35.2 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $178,019 - $201,840	2,819 Added 0.56%	510,423 $35.4 Million
Q4 2022 Feb 21, 2023	SELL	$54.21 - $70.44 $49,439 - $64,241	-912 Reduced 0.18%	507,604 $34.4 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $1.96 Million - $5.01 Million	-36,922 Reduced 6.77%	508,516 $27.9 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $748,868 - $898,996	-12,637 Reduced 2.26%	545,438 $36 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $12.3 Million - $14.8 Million	-220,905 Reduced 28.36%	558,075 $37 Million
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $2.01 Million - $2.37 Million	-37,116 Reduced 4.55%	778,980 $45.4 Million
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $9.02 Million - $9.87 Million	-162,320 Reduced 16.59%	816,096 $49 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $42 Million - $52.2 Million	866,595 Added 774.98%	978,416 $58.6 Million
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $1.24 Million - $1.43 Million	26,250 Added 30.68%	111,821 $5.56 Million
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $767,295 - $917,528	-15,814 Reduced 15.6%	85,571 $4.28 Million
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $76,102 - $87,617	-1,434 Reduced 1.39%	101,385 $5.56 Million
Q2 2020 Aug 11, 2020	BUY	$43.1 - $55.31 $882,601 - $1.13 Million	20,478 Added 24.87%	102,819 $5.44 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $23,089 - $31,362	-611 Reduced 0.74%	82,341 $3.68 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $75,196 - $89,364	-1,771 Reduced 2.09%	82,952 $4.14 Million
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $7.79 Million - $8.83 Million	-194,100 Reduced 69.61%	84,723 $3.78 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $223,680 - $250,080	6,000 Added 2.2%	278,823 $11.5 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $727,545 - $881,910	-20,500 Reduced 6.99%	272,823 $11 Million
Q4 2018 Feb 15, 2019	SELL	$36.86 - $41.49 $1.95 Million - $2.19 Million	-52,900 Reduced 15.28%	293,323 $11.1 Million
Q3 2018 Nov 15, 2018	SELL	$34.76 - $39.72 $677,820 - $774,540	-19,500 Reduced 5.33%	346,223 $13.7 Million
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $404,234 - $433,484	11,700 Added 3.3%	365,723 $12.8 Million
Q1 2018 May 11, 2018	SELL	$32.97 - $36.63 $5.17 Million - $5.74 Million	-156,777 Reduced 30.69%	354,023 $12.4 Million
Q4 2017 Feb 15, 2018	SELL	$32.09 - $34.78 $1.31 Million - $1.42 Million	-40,700 Reduced 7.38%	510,800 $17.7 Million
Q3 2017 Nov 08, 2017	BUY	$28.96 - $34.0 $16 Million - $18.8 Million	551,500	551,500 $18.7 Million

Others Institutions Holding AZN

# of Institutions

1,340

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $219B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Astrazeneca PLC Transaction History